Company Filing History:
Years Active: 2004-2008
Title: The Innovative Contributions of Patrick Salois in Biotechnology
Introduction
Patrick Salois, a distinguished inventor based in Montreal, Canada, has made significant strides in the field of biotechnology. With a notable portfolio of two patents, Salois has made impactful contributions that address critical health concerns, particularly in renal and bone functions.
Latest Patents
Salois's most recent innovations include the patent for Bone Polypeptide-1, which focuses on a specific bone polypeptide along with the nucleic acid molecules that encode it. The invention provides a comprehensive understanding of the human primary sequence of Bone Polypeptide-1 as well as its vertebrate homologs. It also includes engineered cell lines expressing cDNA, antibodies for detection of its translation products, and recombinant adenoviruses for delivering expressible cDNA into host cells. This advancement holds the potential to treat diseases affecting renal and bone functions, marking a significant step forward in therapeutic applications.
His second patent relates to the "Nucleic Acid Molecule, Method and Kit for Selecting a Nucleic Acid Having a Desired Feature." This invention streamlines the screening of nucleic acids by providing a dysfunctional viral genome designed for expressing libraries of exogenous nucleic acids and selecting sequences with predefined characteristics. The innovation further includes a method and a kit that enhances the ability to select nucleic acids crucial for various cellular functions, contributing to advancements in medical research and drug development.
Career Highlights
Throughout his career, Patrick Salois has contributed his expertise to notable companies like Phenogene Therapeutiques Inc. and Enobia Pharma Inc. His work in these organizations has been pivotal in advancing biotechnological research and product development, allowing for the betterment of healthcare solutions.
Collaborations
Salois has collaborated with prominent figures in the field such as Christian Lanctot and Pierre Moffat. These partnerships have enabled him to leverage diverse perspectives and expertise, further enhancing the innovative potential of his research.
Conclusion
Patrick Salois exemplifies the spirit of innovation within the biotechnology sphere. His patents not only reflect his ingenuity but also his commitment to addressing pressing health issues. As he continues to forge ahead in his research endeavors, Salois stands as a significant contributor to the evolution of biotechnology and its applications in medicine.